“Dexmedetomidine Use as Primary Sedative in Neonatal Therapeutic Hypothermia Reduces Opioid Exposure and Adverse Effects”

https://pubmed.ncbi.nlm.nih.gov/38115800

This study found that dexmedetomidine can be used as the primary sedative during neonatal therapeutic hypothermia with a low incidence of adverse effects, resulting in a significant decrease in opioid exposure.